Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review

Leukemia Research

Volumn 36, Issue 9, 2012, Pages

  De Angelis, Federico ^a   Di Rocco, Alice ^a   Minotti, Clara ^a   Valesini, Guido ^a   Cartoni, Claudio ^a   Riminucci, Mara ^b   Conti, Fabrizio ^a   Finolezzi, Erica ^a   Armiento, Daniele ^a   Grammatico, Sara ^a   Massaro, Laura ^a   Fama, Angelo ^a   Colafigli, Gioia ^a   Viccarone, Catrine ^a   Foà, Robin ^a   Martelli, Maurizio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; ETANERCEPT; ETOPOSIDE; KI 67 ANTIGEN; LEUKOSIALIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE PANCREATITIS; ADULT; ANAPLASTIC LARGE T CELL LYMPHOMA; ARTHROCENTESIS; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL INFILTRATION; DRUG WITHDRAWAL; ERYTHEMA; FEVER; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT EFFUSION; LEG EDEMA; LETTER; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SWELLING; T CELL LYMPHOMA; WHOLE BODY CT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RECURRENCE;

EID: 84864004227     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.06.004     Document Type: Letter

References (6)

1. Baecklund E., Sundstrom C., Ekbom A., Catrina A.I., Biberfeld P., Feltelius N., et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003, 48:1543-1550.
2. Shi X.L., Tang X.W., Wu D.P. Pathogenesis of anaplastic large cell lymphoma. Chin J Cancer 2011, 30.
3. Zhang Q., Wang H.Y., Bhutani G., Liu X., Paessler M., Tobias J.W., et al. Lack of TNFα expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis. Proc Natl Acad Sci U S A 2009, 106(September (37)).
4. Dommasch E., Gelfand J.M. Is there truly a risk of lymphoma from biologic therapies?. Dermatol. Ther 2009, 22:418-430.
5. Bongartz T., Warren F.C., Mines D., Matteson E.L., Abrams K.R., Sutton A.J. Etanercept therapy in rheumatoid arthritis and the risk of malignancies. A systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis 2009, 68:1177-1183.
6. Leombruno J.P., Einarson T.R., Keystone E.C. The safety of anti-tumor necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis 2009, 68:1136-1145.